• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Sergio Held

Sergio Held

Articles

ARTICLES

With development slow, experts concerned about biosimilar pharmacovigilance

Sep. 5, 2019
By Sergio Held
SAO PAULO, Brazil – Pharmacovigilance is emerging as a key concern for the development and distribution of biosimilars in Latin America. Experts gathered this week for the BIO Latin America conference focused on the issue and highlighted what they see as a key concern, one that is holding back the spread of that new class of drugs throughout the region.
Read More

LatAm debates the future of personalized medicine

Sep. 4, 2019
By Sergio Held
SAO PAULO, Brazil – Latin America is following the lead of other developed markets by ramping up its focus on personalized medicine, but there are challenges, including the higher costs of those medicines and a lack of regulations.
Read More

Latin American countries join the global ban against Allergan's breast implants

Aug. 27, 2019
By Sergio Held

Counterfeit Herceptin found in the Mexican market

Aug. 27, 2019
By Sergio Held
BOGOTA, Colombia – The Mexican health surveillance agency Cofepris issued an alert about the presence in the country of counterfeited batches of Herceptin (trastuzumab, Roche Holding AG). The alert followed an investigation conducted by the agency after the Swiss drug maker filed a complaint and warned the federal authorities of the counterfeited product in the market.
Read More

Colombian NGO develops 3D printed bionic arms

Aug. 15, 2019
By Sergio Held

Mexican distributor of Indian measles vaccines sanctioned under forgery charges

Aug. 14, 2019
By Sergio Held
BOGOTA, Colombia - Grupo Laboratorios Imperiales Pharma SA de C.V. (Laboratorios Imperiales), from Jiutepec, Mexico, the distributor of measles-rubella (MR) and measles, mumps and rubella (MMR) vaccines manufactured by Serum Institute of India Pvt. Ltd., was banned from signing public contracts with Mexico's public entities for 27 months and fined MX$1.088 million (US$55,478) after it breached two public contracts with the country's Secretariat of Health to provide the country with vaccines.
Read More

Mexican distributor of Indian measles vaccines sanctioned under forgery charges

Aug. 12, 2019
By Sergio Held
BOGOTA, Colombia - Grupo Laboratorios Imperiales Pharma SA de C.V. (Laboratorios Imperiales), from Jiutepec, Mexico, the distributor of measles-rubella (MR) and measles, mumps and rubella (MMR) vaccines manufactured by Serum Institute of India Pvt. Ltd., was banned from signing public contracts with Mexico's public entities for 27 months and fined MX$1.088 million (US$55,478) after it breached two public contracts with the country's Secretariat of Health to provide the country with vaccines.
Read More

Life Si leads bioprinting efforts in Argentina

Aug. 5, 2019
By Sergio Held

Brazilian watchdog Anvisa eyes custom-made devices

July 19, 2019
By Sergio Held

Short supply of GSK's Menveo spurs Argentina vaccine debate

July 11, 2019
By Sergio Held
BOGOTA, Colombia – Argentina, hit by a challenging economic crisis, is struggling to supply vaccines to its population. The most recent shortages affect Menveo, a vaccine produced by Glaxosmithkline plc for preventing meningococcal disease.
Read More
View All Articles by Sergio Held

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 30, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 30, 2025.
  • 3d rendering of bispecific antibodies

    Pfizer bets $6B+ on 3Sbio’s bispecific PD-1/VEGF antibody

    BioWorld
    Pfizer Inc. is paying $1.25 billion up front and up to $4.8 billion in milestone payments to gain global, ex-China rights to SSGJ-707, a PD-1/VEGF bispecific...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 27, 2025
  • KT-621: a first-in-class STAT6 degrader for Th2-driven diseases

    BioWorld Science
    STAT6 plays a central role in regulating Th2-driven immune responses. Recent studies have identified gain-of-function mutations in the STAT6 gene that are...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe